Amyris Company Profile (NASDAQ:AMRS)

About Amyris

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

Industry, Sector and Symbol:

Sector: Oils/Energy
Industry: Specialty Chemicals
Sub-Industry: Oil & Gas Refining & Marketing
Exchange: NASDAQ
Symbol: AMRS
CUSIP: 03236M10

Key Metrics:

Previous Close: $0.50
50 Day Moving Average: $0.4440
200 Day Moving Average: $0.6376
52-Week Range: $0.31 - $2.57
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -4.20
P/E Growth: -0.0900
Market Cap: $136.76M
Outstanding Shares: 235,022,000
Beta: 0.89

Profitability:

Net Margins: -400.17%
Return on Assets: -125.36%

Debt:

Debt-to-Equity Ratio: -0.66%
Current Ratio: 0.17%
Quick Ratio: 0.09%

Additional Links:

Companies Related to Amyris:

Consensus Ratings for Amyris (NASDAQ:AMRS) (?)

Ratings Breakdown:	1 Hold Rating, 3 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$3.20 (534.42% upside)

Analysts' Ratings History for Amyris (NASDAQ:AMRS)

Show:

Date	Firm	Action	Rating	Price Target
9/28/2016	Singular Research	Reiterated Rating	Buy	$2.80
3/10/2016	Cowen and Company	Reiterated Rating	Market Perform	$2.50 -> $2.00
11/10/2015	Rodman & Renshaw	Initiated Coverage	Buy	$4.00
11/10/2015	HC Wainwright	Initiated Coverage	Buy	$4.00

(Data available from 9/30/2014 forward)

Earnings History for Amyris (NASDAQ:AMRS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/3/2016
8/4/2016	Q2	($0.12)	($0.06)	$15.23 million	$9.60 million	View	N/A
5/10/2016	Q1	($0.13)	($0.17)	$10.39 million	$8.80 million	View	Listen
3/9/2016	Q4	($0.10)	($0.16)	$32.44 million	$9.80 million	View	Listen
11/5/2015	Q315	($0.14)	($0.23)	$8.84 million	$8.60 million	View	N/A
8/6/2015	Q215	($0.31)	($0.47)	$15.66 million	$7.80 million	View	N/A
5/5/2015	Q115	($0.20)	($0.41)	$21.40 million	$7.90 million	View	N/A
2/24/2015	Q414	($0.27)	($0.40)	$20.12 million	$11.60 million	View	N/A
11/4/2014	Q314	($0.24)	($0.28)	$20.51 million	$16.34 million	View	N/A
8/7/2014	Q214	($0.30)	($0.40)	$12.36 million	$9.30 million	View	N/A
5/8/2014	Q114	($0.28)	($0.10)	$13.50 million	$17.90 million	View	N/A
2/25/2014	Q413	($0.24)	($0.26)	$18.66 million		View	N/A
10/31/2013	Q313	($0.30)	($0.32)	$13.59 million	$7.00 million	View	N/A
8/8/2013	Q2 2013	($0.32)	($0.34)	$11.47 million	$10.80 million	View	N/A
4/30/2013	Q1 2013	($0.39)	($0.39)	$9.80 million	$7.87 million	View	N/A
2/19/2013	Q4 2012	($0.51)	($0.49)	$10.68 million	$5.90 million	View	N/A
11/6/2012	Q312	($0.63)	($0.22)	$10.49 million	$19.10 million	View	N/A
7/31/2012		($0.69)	($0.66)			View	N/A
5/8/2012		($0.76)	($1.88)			View	N/A
11/1/2011		($0.71)	($0.97)			View	N/A
8/2/2011		($0.63)	($0.95)			View	N/A
5/5/2011		($0.50)	($0.76)			View	N/A
2/28/2011		($0.49)	($0.51)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Amyris (NASDAQ:AMRS)

Current Year EPS Consensus Estimate: $-0.2 EPS
Next Year EPS Consensus Estimate: $-0.12 EPS

Dividend History for Amyris (NASDAQ:AMRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Amyris (NASDAQ:AMRS)

Insider Ownership Percentage: 48.70%
Institutional Ownership Percentage: 35.68%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/14/2016	L John Doerr	Director	Buy	200,577	$1.04	$208,600.08
10/14/2015	Energies Nouvelles Activ Total	Director	Sell	80,052	$2.36	$188,922.72
6/5/2015	John Melo	CEO	Sell	61,276	$2.00	$122,552.00
5/12/2015	John Melo	CEO	Sell	65,575	$2.08	$136,396.00
5/15/2014	L John Doerr	Director	Buy	172,186	$3.02	$520,001.72
5/24/2013	John Melo	CEO	Sell	24,402	$2.85	$69,545.70
3/27/2013	Thani Sheikh Abdullah Bin K Al	Director	Buy	1,533,742	$3.26	$4,999,998.92
12/24/2012	Thani Sheikh Abdullah Bin K Al	Director	Buy	3,355,704	$2.98	$9,999,997.92
8/31/2012	John Melo	CEO	Sell	668,730	$3.70	$2,474,301.00
8/31/2012	L John Doerr	Director	Buy	270,270	$3.70	$999,999.00

(Data available from 1/1/2013 forward)

Latest Headlines for Amyris (NASDAQ:AMRS)

Date	Headline
	Ginkgo Bioworks Unveils Next Generation Organism Foundry to Bring Biotech into New Markets (NASDAQ:AMRS) www.prnewswire.com - September 30 at 3:55 PM
	Amyris (AMRS) Enters New Funding Arrangement, Expanded Nutraceutical Collaboration (NASDAQ:AMRS) www.streetinsider.com - September 30 at 3:55 PM
	Can The Uptrend Continue for Amyris (AMRS)? (NASDAQ:AMRS) finance.yahoo.com - September 30 at 3:55 PM
	Amyris Inc (AMRS) Stock Gaining Big On Funding And Collaboration News (NASDAQ:AMRS) feedproxy.google.com - September 30 at 3:46 PM
	Amyris Expands in Global Nutraceuticals Market with New Collaboration and Partner Funding of $30 Million (NASDAQ:AMRS) finance.yahoo.com - September 30 at 8:38 AM
	Insider Trading and Upgrades/Downgrades for Amyris, Inc. (NASDAQ:AMRS) - Newburgh Press (NASDAQ:AMRS) newburghpress.com - September 29 at 3:42 PM
	2 Stocks Analyst-Opinion Need Close Attention Cobalt International ... - The Voice Registrar (NASDAQ:AMRS) voiceregistrar.com - September 28 at 8:17 AM
	Under the Microscope: Zeroing in on Shares of Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 26 at 8:28 PM
	ETF’s with exposure to Amyris, Inc. : September 26, 2016 (NASDAQ:AMRS) www.capitalcube.com - September 26 at 3:27 PM
	Under the Microscope, Zeroing in at Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 23 at 3:54 PM
	Keen Investors Find News on Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 23 at 3:54 PM
	Penny Stock Investors Keen on Shares of Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 21 at 4:23 PM
	Trending Stocks: EnteroMedics Inc (NASDAQ:ETRM), Amyris Inc (NASDAQ:AMRS) - NYSE Journal (press release) (NASDAQ:AMRS) stockznews.com - September 21 at 4:23 PM
	Penny Stock Investors Take an Interest in Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 20 at 3:29 PM
	Amyris Inc (NASDAQ:AMRS) & Baxter International Inc (NYSE:BAX ... - Money News (NASDAQ:AMRS) www.newsismoney.com - September 19 at 4:25 PM
	Basic materials stocks for your portfolio: QEP Resources, Inc. (QEP), Amyris, Inc. (AMRS) - The Independent Republic (NASDAQ:AMRS) theindependentrepublic.com - September 19 at 8:14 AM
	Amyris, Inc.'s (AMRS): Stock to Watch - Hot Stocks Point (NASDAQ:AMRS) www.hotstockspoint.com - September 19 at 8:14 AM
	Amyris : & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products (NASDAQ:AMRS) www.4-traders.com - September 18 at 8:16 AM
	AMRS Amyris, Inc. $AMRS Company (NASDAQ:AMRS) investorshangout.com - September 18 at 8:16 AM
	Basic materials stocks for your portfolio: Commercial Metals Company (CMC), Amyris, Inc. (AMRS) - The Independent Republic (NASDAQ:AMRS) theindependentrepublic.com - September 16 at 3:29 PM
	Stocks Faring Away From Broker's Choice: AcelRx Pharmaceuticals (NASDAQ:ACRX), Amyris (AMRS), CME Group ... - Street Wise Report (press release) (blog) (NASDAQ:AMRS) streetwisereport.com - September 16 at 3:29 PM
	Amyris, Inc. (NASDAQ:AMRS) Sale Analysis - Newburg Press (NASDAQ:AMRS) newburghpress.com - September 16 at 3:29 PM
	Amyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22 (NASDAQ:AMRS) www.nasdaq.com - September 16 at 12:10 PM
	Amyris to Present at Singular Research 11th Annual "Best of The Uncovereds" Conference September 22, 2016 (NASDAQ:AMRS) finance.yahoo.com - September 16 at 12:10 PM
	Keen Investors Narrowing Their Focus on Amyris, Inc. (NASDAQ:AMRS) - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 15 at 12:23 PM
	Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products (NASDAQ:AMRS) www.publicnow.com - September 15 at 12:23 PM
	Keen Investors Narrowing Their Focus on Amyris, Inc. (NASDAQ ... - Duncan Research (NASDAQ:AMRS) www.duncanindependent.com - September 14 at 8:45 PM
	Basic materials stocks for your portfolio: Amyris, Inc. (AMRS), Jones Energy, Inc. (JONE) - The Independent Republic (NASDAQ:AMRS) theindependentrepublic.com - September 12 at 3:29 PM
	Amyris, Inc. (NASDAQ:AMRS) Quarterly Analysis - Newburg Press (NASDAQ:AMRS) newburghpress.com - September 12 at 3:29 PM
	Is Amyris (AMRS) Stock a Solid Choice Right Now? (NASDAQ:AMRS) www.zacks.com - September 12 at 8:17 AM
	AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (NASDAQ:AMRS) biz.yahoo.com - September 10 at 8:14 AM
	Amyris in Partnership with Boticário Group Named Gold Winner by Cosmetics Design for Breakthrough Ingredient ─ Neossance® Hemisqualane (NASDAQ:AMRS) finance.yahoo.com - September 9 at 3:27 PM
	ETF’s with exposure to Amyris, Inc. : September 9, 2016 (NASDAQ:AMRS) www.capitalcube.com - September 9 at 3:27 PM
	Stocks in Focus: Amyris, Inc. (AMRS), U.S. Silica Holdings, Inc. (SLCA), Progenics Pharmaceuticals, Inc. (PGNX) - iStreetWire (NASDAQ:AMRS) istreetwire.com - September 8 at 3:27 PM
	Basic Materials Stocks To Look Out For: Amyris, Inc. (AMRS), Alon USA Energy, Inc. (ALJ) - The Independent Republic (NASDAQ:AMRS) theindependentrepublic.com - September 8 at 3:27 PM
	Amyris to Present at Rodman & Renshaw 18th Annual Global Investment Conference on September 12, 2016 (NASDAQ:AMRS) finance.yahoo.com - September 7 at 12:26 PM
	Who Is Driving Apple's Management Team? (APPL) (NASDAQ:AMRS) www.investopedia.com - September 2 at 3:30 PM
	Amyris, Inc.'s (AMRS): Traders Alert - Hot Stocks Point (NASDAQ:AMRS) www.hotstockspoint.com - August 25 at 8:18 AM
	Biossance™ Launches The Detoxifier - A Breakthrough, Innovative Modeling Mask (NASDAQ:AMRS) www.nasdaq.com - August 24 at 11:45 AM
	Biossance™ Launches The Detoxifier ─ A Breakthrough, Innovative Modeling Mask (NASDAQ:AMRS) www.publicnow.com - August 24 at 11:45 AM
	ETF’s with exposure to Amyris, Inc. : August 23, 2016 (NASDAQ:AMRS) www.capitalcube.com - August 23 at 3:29 PM
	ETF’s with exposure to Amyris, Inc. : August 23, 2016 (NASDAQ:AMRS) www.capitalcube.com - August 23 at 3:29 PM
	Amyris, Inc. (NASDAQ:AMRS), Biossance Introduces The Illuminator - Journal Transcript (NASDAQ:AMRS) www.journaltranscript.com - August 19 at 4:06 PM
	AMYRIS, INC. Financials (NASDAQ:AMRS) finance.yahoo.com - August 19 at 4:06 PM
	Amyris, Inc.'s (AMRS): Stocks on Trader's Radar - Hot Stocks Point (NASDAQ:AMRS) www.hotstockspoint.com - August 18 at 3:36 PM
	Amyris Inc (NASDAQ:AMRS) & Wynn Resorts, (NASDAQ:WYNN) Notable Runners - Money News (press release) (NASDAQ:AMRS) www.newsismoney.com - August 18 at 3:36 PM
	Amyris : Biossance™ Launches The Illuminator ─ A Clinically Proven, Weightless Eye Gel (NASDAQ:AMRS) www.4-traders.com - August 18 at 11:53 AM
	Amyris: The New Colossus Aims To Unlock Its Golden Door (NASDAQ:AMRS) www.altenergystocks.com - August 17 at 8:58 PM
	Amyris - A Juggernaut In The Making (NASDAQ:AMRS) seekingalpha.com - August 17 at 8:58 PM
	Amyris (AMRS) Announces Biossance Launches The Illuminator (NASDAQ:AMRS) www.streetinsider.com - August 17 at 8:58 PM